These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11812409)

  • 1. Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn's disease after treatment with a tumor necrosis factor-alpha inhibitor.
    Wagner TE; Huseby ES; Huseby JS
    Am J Med; 2002 Jan; 112(1):67-9. PubMed ID: 11812409
    [No Abstract]   [Full Text] [Related]  

  • 2. Ileocolonic tuberculosis clinically, endoscopically, and radiologically mimicking Crohn's disease: disseminated infection after treatment with infliximab.
    Cappell MS; Saad A; Bortman JS; Amin M
    J Crohns Colitis; 2014 Jun; 8(6):560-2. PubMed ID: 24360259
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for).
    Shanahan F
    Inflamm Bowel Dis; 2000 May; 6(2):137-9. PubMed ID: 10833074
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
    Izbéki F; Nagy F; Szepes Z; Kiss I; Lonovics J; Molnár T
    Inflamm Bowel Dis; 2008 Mar; 14(3):429-31. PubMed ID: 17973302
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?
    van Deventer SJ
    Gut; 2002 Sep; 51(3):362-3. PubMed ID: 12171957
    [No Abstract]   [Full Text] [Related]  

  • 6. Pericarditis as a complication of infliximab therapy in Crohn's disease.
    Burke JP; Kelleher B; Ramadan S; Quinlan M; Sugrue D; O'Donovan MA
    Inflamm Bowel Dis; 2008 Mar; 14(3):428-9. PubMed ID: 17924565
    [No Abstract]   [Full Text] [Related]  

  • 7. Infliximab treatment for Crohn's disease.
    Conroy CA; Cattell R
    Postgrad Med J; 2001 Jul; 77(909):436-40. PubMed ID: 11423591
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing TB in patients with Crohn's disease needing infliximab or other anti-TNF therapy.
    Rampton DS
    Gut; 2005 Oct; 54(10):1360-2. PubMed ID: 16113045
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease.
    Ritz MA; Jost R
    Inflamm Bowel Dis; 2001 Nov; 7(4):327. PubMed ID: 11720324
    [No Abstract]   [Full Text] [Related]  

  • 10. Disseminated tuberculosis in a Crohn's disease patient on anti-TNF alpha therapy despite chemoprophylaxis.
    Bourikas LA; Kourbeti IS; Koutsopoulos AV; Koutroubakis IE
    Gut; 2008 Mar; 57(3):425; author reply 425-6. PubMed ID: 18268059
    [No Abstract]   [Full Text] [Related]  

  • 11. The myth of gastrointestinal sarcoidosis: a case of guilt by association.
    Sachar DB; Rochester J
    Inflamm Bowel Dis; 2004 Jul; 10(4):441-3. PubMed ID: 15475756
    [No Abstract]   [Full Text] [Related]  

  • 12. Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist.
    Angelucci E; Cocco A; Viscido A; Vernia P; Caprilli R
    Inflamm Bowel Dis; 2007 Aug; 13(8):1059-61. PubMed ID: 17387676
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy.
    Dubcenco E; Ottaway CA; Chen DL; Baker JP
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):565-6. PubMed ID: 16607158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of acute and necrotizing cutaneous Mycobacterium marinum infection in a patient treated with infliximab for Crohn's disease].
    Guyot A; Begon E; Abramowitz L; Landry J; Marinho E; Descamps V; Crickx B
    Ann Dermatol Venereol; 2009 Nov; 136(11):806-10. PubMed ID: 19917434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adalimumab in infliximab refractory Crohn's disease -- the next generation of anti-TNF-alpha-therapy?].
    Heidemann J; Kucharzik T
    Z Gastroenterol; 2005 Jul; 43(7):689-90. PubMed ID: 16001352
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral neuropathy with infliximab therapy in inflammatory bowel disease.
    Burger DC; Florin TH
    Inflamm Bowel Dis; 2009 Dec; 15(12):1772. PubMed ID: 19170193
    [No Abstract]   [Full Text] [Related]  

  • 17. Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M; Melliez H; Seguy D; Viget N; Cortot A; Colombel JF
    Inflamm Bowel Dis; 2005 Jun; 11(6):618-20. PubMed ID: 15905713
    [No Abstract]   [Full Text] [Related]  

  • 18. TNF-alpha antagonists for the treatment of Crohn's disease.
    Kam LY; Targan SR
    Expert Opin Pharmacother; 2000 May; 1(4):615-22. PubMed ID: 11249506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual presentation of tuberculosis after infliximab therapy.
    Magro F; Pereira P; Veloso FT; Carneiro F
    Inflamm Bowel Dis; 2005 Jan; 11(1):82-4. PubMed ID: 15674123
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab-induced thrombocytopenia in an elderly patient with ileocolonic Crohn's disease.
    Mocciaro F; Russo G; Di Mitri R; Marino A
    Inflamm Bowel Dis; 2013; 19(4):E52-3. PubMed ID: 22535599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.